Invention Grant
- Patent Title: Antibodies against ILT2
-
Application No.: US17224016Application Date: 2021-04-06
-
Publication No.: US11236162B2Publication Date: 2022-02-01
- Inventor: Ilana Mandel , Tsuri Peretz , Dana Haves Ziv , Ilana Goldshtein , Dror Alishekevitz , Anna Fridman-Dror , Motti Hakim , Avidor Shulman , Yair Sapir , Tehila Ben-Moshe
- Applicant: Biond Biologics Ltd.
- Applicant Address: IL Misgav
- Assignee: Biond Biologics Ltd.
- Current Assignee: Biond Biologics Ltd.
- Current Assignee Address: IL Misgav
- Agency: Steptoe & Johnson LLP
- Agent Z. Ying Li; Wyan-Ching M. Lee
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61K39/00 ; A61K45/06
Abstract:
The present invention provides monoclonal antibodies, or antigen-binding portions thereof, against ILT2, as well as pharmaceutical compositions comprising same and methods of producing same. Also provided are methods of treating cancer comprising administering the antibodies or compositions of the invention. Methods of treating cancer, combination treatments, and patient selection are also provided.
Public/Granted literature
- US20210277112A1 Antibodies Against ILT2 and Use Thereof Public/Granted day:2021-09-09
Information query
